11.07
Precedente Chiudi:
$11.14
Aprire:
$11.14
Volume 24 ore:
2.05M
Relative Volume:
0.70
Capitalizzazione di mercato:
$2.78B
Reddito:
$496.43M
Utile/perdita netta:
$71.35M
Rapporto P/E:
38.86
EPS:
0.2849
Flusso di cassa netto:
$151.57M
1 W Prestazione:
+2.59%
1M Prestazione:
-4.73%
6M Prestazione:
-20.93%
1 anno Prestazione:
-41.01%
Cellebrite Di Ltd Stock (CLBT) Company Profile
Nome
Cellebrite Di Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare CLBT vs MSFT, PLTR, ORCL, CRWD, FTNT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CLBT
Cellebrite Di Ltd
|
11.07 | 2.71B | 496.43M | 71.35M | 151.57M | 0.2849 |
|
MSFT
Microsoft Corp
|
517.53 | 3.81T | 318.27B | 125.22B | 72.92B | 16.79 |
|
PLTR
Palantir Technologies Inc
|
188.75 | 456.68B | 5.22B | 2.29B | 2.69B | 0.8876 |
|
ORCL
Oracle Corp
|
142.30 | 414.55B | 67.36B | 17.31B | -23.69B | 5.8248 |
|
CRWD
Crowdstrike Holdings Inc
|
270.04 | 258.16B | 5.09B | -24.89M | 1.43B | -0.0471 |
|
FTNT
Fortinet Inc
|
180.95 | 127.27B | 7.11B | 1.95B | 2.44B | 2.5883 |
Cellebrite Di Ltd Stock (CLBT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-28 | Reiterato | Needham | Buy |
| 2024-03-13 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-02-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-07-19 | Iniziato | Craig Hallum | Buy |
| 2022-08-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-08-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-02-24 | Iniziato | JP Morgan | Overweight |
| 2022-02-11 | Iniziato | Deutsche Bank | Buy |
| 2021-12-02 | Iniziato | BofA Securities | Buy |
| 2021-10-21 | Iniziato | Citigroup | Buy |
Mostra tutto
Cellebrite Di Ltd Borsa (CLBT) Ultime notizie
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd.CLBT - PR Newswire
Cellebrite DI Ltd. (CLBT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ETFs Investing in Cellebrite DI Ltd. Stocks - TradingView
Form 4 Cellebrite DI Ltd. For: 29 September By Investing.com - Investing.com South Africa
Kaplan Fox Advises Investors of Cellebrite DI Ltd. (NASDAQ: CLBT) - The National Law Review
A director's 15,190-share grant at Cellebrite (CLBT) is scheduled to vest September 17, 2027. - Stock Titan
Cellebrite Director Yonatan Domnitz Awarded 15,190 RSUs in September 2026 - Kalkine Media
Cellebrite's 2026 Outlook: Subscription Pivot Weighs on the Stock Today, Helps Lead a Future Rebound - Yahoo Finance
Cellebrite's 2026 Outlook: Subscription Pivot Weighs on the Stock Today, Helps Lead a Future Rebound - The Motley Fool
Pretax income of Cellebrite DI Ltd. – HAN:9W9 - TradingView
Director Adam Clammer receives a share-unit award at Cellebrite (CLBT); it vests in 2027. - Stock Titan
Cellebrite faces securities investigation after missing revenue targets and sudden CEO change. - Pluang
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Is Cellebrite DI Ltd (CLBT) a Bargain After 5.1% Drop? GF Value Says Undervalued - GuruFocus
Cellebrite DI Shareholders Approve Board, Executive Pay and Auditor at 2026 Annual Meeting - theglobeandmail.com
Cellebrite (CLBT) CEO Ramji Shiven’s share award begins vesting in May 2027 - Stock Titan
Cellebrite DI (NASDAQ:CLBT) Stock Price Down 5.5%Here's Why - MarketBeat
Kaplan Fox Notifies Cellebrite DI Ltd. (NASDAQ: CLBT) Investors of an Investigation Into Possible Securities Law Violations - The Globe and Mail
Cellebrite DI Ltd. (NASDAQ:CLBT) Stock Rated "Moderate Buy" by Sell-Side Analysts - MarketBeat
Cellebrite DI Ltd. (CLBT) stock price, news, quote and history - Yahoo Finance UK
About 80.9% of Cellebrite (CLBT) shares were represented at the meeting that re-elected two directors. - Stock Titan
Cellebrite DI Ltd. (CLBT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Kaplan Fox Alerts Cellebrite DI Ltd. (NASDAQ: CLBT) Investors to - The National Law Review
Kaplan Fox Alerts Cellebrite DI Ltd. (NASDAQ: CLBT) Investors to an Ongoing Investigation Into Possible Securities Law Violations - The Globe and Mail
Cellebrite Calls for 2027 JUSTYS Nominees, Premier Event Highlights Unsung Heroes Who Keep the World Safe - marketscreener.com
An awards ceremony honoring investigators will stream to 7.7 million YouTube subscribers. - Stock Titan
Cellebrite stock holds at USD 11.62 as 2026 targets stay intact - AD HOC NEWS
Cellebrite DI Ltd (9W9.DU) stock price, news, quote and history - Yahoo Finance UK
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBT - FinancialContent
Is Cellebrite DI (CLBT) A Bargain On Its Subscription Growth Narrative? - Yahoo Finance
Kaplan Fox Encourages Cellebrite DI Ltd. (NASDAQ: CLBT) Investors to Contact the Firm Regarding an Ongoing Securities Investigation - The Globe and Mail
Cellebrite DI Ltd. (NASDAQ: CLBT) Grants Director Richardson Troy 15,190 Shares at No Cost - Kalkine Media
Cellebrite DI (CLBT) Faces A Probe And CEO Change, Is It Still Cheap? - Simply Wall Street
Cellebrite expands The 101 for forensics experts - SourceSecurity.com
Cellebrite Expands Digital Forensics Community - SecurityInformed.com
Kaplan Fox is Investigating Cellebrite DI Ltd. (NASDAQ: CLBT) for Possible Securities Law Violations - NewMediaWire
Cellebrite (CLBT) Q2 2026 Earnings: EPS Slightly Misses Estimate as Shares Edge HigherEPS Estimate Trend - careplusvn.com
Cellebrite expands digital community for forensics professionals By Investing.com - Investing.com Nigeria
Cellebrite expands digital community for forensics professionals - Investing.com
Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals - aap.com.au
Cellebrite Director Dafna Gruber Awarded 15,190 RSUs, Boosting Share Ownership - Kalkine Media
Equity grant lifts Cellebrite (CLBT) director’s stake - Stock Titan
CLBT Investors Have Opportunity to Join Cellebrite DI Ltd. Fraud Investigation with SBS Law - Business Wire
62,000 investigators are already sharing knowledge in Cellebrite’s global network - Stock Titan
Director at Cellebrite (CLBT) gets 15,190-share equity grant - Stock Titan
Cellebrite (CLBT) director now holds 43,109 shares after RSU grant - Stock Titan
Cellebrite DI Ltd. (CLBT) director now holds 50,744 shares after RSU grant - Stock Titan
Cellebrite DI Ltd (CLBT) Stock Down 3.7% -- Now Undervalued? GF Score: 77/100 - GuruFocus
Cellebrite DI (NASDAQ:CLBT) Receives "Buy" Rating from DA Davidson - MarketBeat
Cellebrite Initiates Plans to Redomicile in the United States - Japan Wire by Kyodo News
Cellebrite DI Ltd. (NASDAQ:CLBT) Puts Labs Under CTO Chris Wade - TradingView
Cellebrite Di Ltd Azioni (CLBT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cellebrite Di Ltd Azioni (CLBT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| GEE DAVID NICHOLAS | Chief Marketing Officer |
Aug 24 '26 |
Sale |
11.36 |
4,323 |
49,111 |
135,281 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):